Get the Stockscreener App
13.73
2.08%
0.28
Calumet Inc stock is traded at $13.73, with a volume of 800.53K.
It is up +2.08% in the last 24 hours and up +45.83% over the past month.
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.
See More
Previous Close:
$13.45
Open:
$13.29
24h Volume:
800.53K
Relative Volume:
0.63
Market Cap:
$1.19B
Revenue:
$4.15B
Net Income/Loss:
$-22.20M
P/E Ratio:
-196.14
EPS:
-0.07
Net Cash Flow:
$-243.60M
1W Performance:
+11.44%
1M Performance:
+45.83%
6M Performance:
-34.37%
1Y Performance:
-12.83%
1-Day Range:
$13.04
$13.74
1-Week Range:
$12.63
$14.12
52-Week Range:
$7.68
$25.29
Calumet Inc Stock (CLMT) Company Profile
Name
Calumet Inc
Sector
Industry
Phone
(317) 328-5660
Address
1060 N CAPITOL AVE, INDIANAPOLIS
Compare CLMT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLMT
Calumet Inc
|
13.73 | 1.07B | 4.15B | -22.20M | -243.60M | -0.07 |
|
LIN
Linde plc Ordinary Share
|
457.77 | 213.08B | 33.02B | 6.61B | 4.91B | 13.77 |
|
SHW
Sherwin Williams Co
|
363.51 | 88.18B | 23.04B | 2.68B | 2.18B | 10.58 |
|
ECL
Ecolab Inc
|
259.09 | 71.64B | 15.68B | 2.10B | 1.50B | 7.36 |
|
APD
Air Products Chemicals Inc
|
278.93 | 60.34B | 12.02B | 1.53B | -4.33B | 6.88 |
|
DD
Dupont De Nemours Inc
|
69.32 | 27.94B | 12.39B | 703.00M | 1.42B | 1.67 |
Calumet Inc Stock (CLMT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-13-25 | Initiated | BofA Securities | Buy |
| Mar-17-25 | Upgrade | UBS | Sell → Neutral |
| Mar-04-25 | Downgrade | TD Cowen | Buy → Hold |
| Feb-04-25 | Downgrade | UBS | Neutral → Sell |
| Nov-11-24 | Reiterated | TD Cowen | Buy |
| Oct-17-24 | Reiterated | TD Cowen | Buy |
| Aug-12-24 | Reiterated | TD Cowen | Buy |
| Aug-18-22 | Upgrade | Goldman | Neutral → Buy |
| Feb-28-22 | Reiterated | Cowen | Outperform |
| Jan-06-22 | Initiated | Credit Suisse | Neutral |
| Nov-23-21 | Upgrade | Cowen | Market Perform → Outperform |
| Nov-23-21 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-04-21 | Initiated | H.C. Wainwright | Buy |
| Mar-24-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-11-20 | Upgrade | Raymond James | Underperform → Mkt Perform |
| Sep-05-17 | Downgrade | Janney | Buy → Neutral |
| Aug-14-17 | Upgrade | Janney | Neutral → Buy |
| May-10-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Mar-24-17 | Downgrade | Credit Suisse | Neutral → Underperform |
| Nov-04-16 | Upgrade | Credit Suisse | Underperform → Neutral |
| Sep-09-16 | Initiated | FBR Capital | Mkt Perform |
| May-06-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| May-05-16 | Reiterated | Cowen | Market Perform |
| May-05-16 | Upgrade | DA Davidson | Underperform → Neutral |
| Apr-22-16 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Apr-19-16 | Downgrade | DA Davidson | Buy → Underperform |
| Apr-18-16 | Reiterated | Cowen | Market Perform |
| Apr-18-16 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Apr-18-16 | Reiterated | Scotia Howard Weil | Sector Underperform |
| Apr-18-16 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Apr-11-16 | Downgrade | Credit Suisse | Outperform → Underperform |
| Feb-19-16 | Downgrade | Credit Suisse | Outperform → Neutral |
| Feb-18-16 | Reiterated | RBC Capital Mkts | Outperform |
View All
Calumet Inc Stock (CLMT) Latest News
Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
A ‘sustainable’ shift at the Great Falls refinery could come with costs to locals - Montana Free Press
Insider Sell Alert: Daniel Sheets Sells 40,000 Shares of Calumet Inc (CLMT) - GuruFocus
Bank of America Initiates Coverage on Calumet Specialty Products Partners (NASDAQ:CLMT) - MarketBeat
HC Wainwright Has Negative Forecast for CLMT FY2029 Earnings - MarketBeat
Calumet Specialty Products Partners (NASDAQ:CLMT) Posts Earnings Results, Misses Estimates By $0.62 EPS - MarketBeat
Calumet (CLMT) Price Target Reduced as Cost Efficiency Improves - GuruFocus
BofA sets Calumet stock to Buy, $15 target on biofuel prospects - Investing.com Nigeria
Montana Renewables to expedite first phase of MaxSAF initiative - Biomass Magazine
Calumet Renewables Expansion Is Unlocking Value: Analyst - AOL.com
Calumet (CLMT) Receives Buy Rating Due to Promising Biofuel Expa - GuruFocus
Calumet launched at Buy by BofA, as renewables growth seen driving deleveraging - Seeking Alpha
Calumet (CLMT) Receives 'Buy' Rating from B of A Securities | CL - GuruFocus
BofA Securities Initiates Calumet at Buy With $15 Price Target - marketscreener.com
Calumet, Inc. /DE SEC 10-Q Report - TradingView
Calumet, Inc. (NASDAQ:CLMT) Q1 2025 Earnings Call Transcript - Insider Monkey
Calumet Q1 2025 slides: MaxSAF acceleration and improved renewables performance - Investing.com
Calumet outlines $20M–$30M capital plan for MaxSAF 150 expansion with early 2026 target - MSN
Calumet Specialty Products Reports Q1 2025 Results - TipRanks
Calumet earnings missed by $1.49, revenue topped estimates - Investing.com Nigeria
Earnings call transcript: Calumet Inc. reports Q1 2025 earnings miss By Investing.com - Investing.com India
Calumet (CLMT) Reports Q1 EPS Loss, Revenue Dips Slightly - GuruFocus
Calumet (CLMT) Achieves Key Milestones Amid Deleveraging Efforts - GuruFocus
Earnings call transcript: Calumet Inc. reports Q1 2025 earnings miss - Investing.com
CLMT Reports Q1 Revenue Drop, Accelerates Growth Plans | CLMT St - GuruFocus
Earnings Flash (CLMT) Calumet Posts Q1 Sales $993.9M, vs. FactSet Est of $891.4M - marketscreener.com
CLMT Reports Q1 Revenue Drop, Accelerates Growth Plans | CLMT Stock News - GuruFocus
Calumet Reports First Quarter 2025 Results - Yahoo Finance
Calumet Inc (CLMT) Q1 2025: Everything You Need to Know Ahead of Earnings - GuruFocus
Calumet Specialty Products Partners (CLMT) Expected to Announce Earnings on Friday - MarketBeat
Calumet Specialty Products Partners (NASDAQ:CLMT) Trading Up 4.6%Still a Buy? - MarketBeat
Calumet: Debt Relief Or Just Delaying The Inevitable? (NASDAQ:CLMT) - Seeking Alpha
Calumet Inc (CLMT) Stock Price Up 3.2% on Apr 28 - GuruFocus
Calumet Specialty Products Partners (NASDAQ:CLMT) Shares Down 2.8%Time to Sell? - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
Calumet, Inc. to Release First Quarter 2025 Earnings on May 9, 2 - GuruFocus
Calumet, Inc. to Release First Quarter 2025 Earnings on May 9, 2025 - Yahoo Finance
Polyol Ester Market Set to Witness Significant Growth by 2032 | - openPR.com
Brokerages Set Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) PT at $19.80 - MarketBeat
Calumet's Businesses Firing Like A Cannon, Well, Even Much Closer (Update) (NASDAQ:CLMT) - Seeking Alpha
Calumet Specialty Products Partners (NASDAQ:CLMT) Shares Up 5.2%Should You Buy? - MarketBeat
It's Down 29% But Calumet, Inc. (NASDAQ:CLMT) Could Be Riskier Than It Looks - simplywall.st
Calumet Specialty Products Partners (NASDAQ:CLMT) Stock Price Down 12.3% on Analyst Downgrade - MarketBeat
Calumet, Inc. (CLMT): A Bull Case Theory - Insider Monkey
Calumet Inc Stock (CLMT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.87%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):